MIA
REGN icon

MMBG Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

MMBG Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Hold
370
– – 0.02% 172
2026
Q1 		$286K Hold
370
– – 0.03% 159
2025
Q4 		$286K Hold
370
– – 0.02% 164
2025
Q3 		$208K Buy
+370
New +$209K 0.02% 177
2025
Q2 		– Sell
-370
Closed -$235K – 180
2025
Q1 		$235K Hold
370
– – 0.03% 164
2024
Q4 		$264K Buy
+370
New +$311K 0.03% 155

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

MMBG Investment Advisors's REGN Position: Q2 2026 in Review

MMBG Investment Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 370 shares worth $231K. The position accounts for 0.02% of the portfolio, ranked #172.

MMBG Investment Advisors first reported a position in REGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $286K in Q1 2026. 866 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • MMBG Investment Advisors held 370 shares of Regeneron Pharmaceuticals worth $231K as of Q2 2026.
  • MMBG Investment Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.02% of MMBG Investment Advisors's portfolio in Q2 2026, its #172 holding.
  • MMBG Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • MMBG Investment Advisors's Regeneron Pharmaceuticals position peaked at $286K in Q1 2026.
  • 866 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.